Predictors of time to death among cervical cancer patients at Tikur Anbesa specialized hospital from 2014 to 2019: A survival analysis.

Benyam Seifu, Chaltu Fikru, Delelegn Yilma, Fasil Tessema
Author Information
  1. Benyam Seifu: Collage of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia. ORCID
  2. Chaltu Fikru: Faculty of Public Health, Jimma University, Jimma, Ethiopia.
  3. Delelegn Yilma: College of Medicine and Health Science, Ambo University, Ambo, Ethiopia.
  4. Fasil Tessema: Faculty of Public Health, Jimma University, Jimma, Ethiopia.

Abstract

BACKGROUND: Cervical cancer (CC) is the 4th most prevalent cancer among females globally. In Ethiopia, around 7,095 new CC cases are diagnosed every year and it is the second common cause of cancer deaths in women. There is limited evidence on survival status as well as about predictors of time to death among CC patients in Ethiopia. Thus, this study investigated the five-year survival status and predictors of time to death among CC patients who had been admitted at Tikur Anbesa specialized Hospital (TASH) from 2014-2019.
METHODS: Facility-based, retrospective-cohort study was conducted at Tikur Anbesa specialized Hospital among 348 patients from June 2014 to June 2019. A systematic random sampling method was employed to select the study participants. Data were extracted from the patient card, and through phone calls. The data was collected using the android version CS-Entry tool. Data was analyzed by SPSS version 23. Kaplan and Meier's method was used to estimate survival functions and Cox-proportional hazard regression analysis was carried out in order to identify the independent predictors of time to death.
RESULTS: The overall incidence of death was 31 per 100 person-years of follow up. The median (IQR) follow-up time of the entire cohorts was 18.55 (8.96-49.65) months. The independent predictors for time to death included; age older than 50 years [AHR: 1.4; 95% CI: 1.1-1.9], late stage of CC at diagnosis [AHR: 2.2; 95% CI: 1.7-2.9], No CC treatment [AHR: 2.1; 95% CI: 1.5-3.1] and HIV positive [AHR: 2.3; 95% CI: 1.4-3.8].
CONCLUSION AND RECOMMENDATION: The death rate of CC patients was high. The significant predictors associated with shorten time to death of CC patients were older age, advanced cancer stage at diagnosis, HIV infection and not receiving cancer treatment. Therefore, improving early detection and initiation of treatment for all CC patients is necessary in order to improve patient's survival status. The government needs to strengthen the routine CC screening programs to address high-risk women such as elderly and HIV positive women in Ethiopia.

References

  1. J Clin Oncol. 2002 Feb 15;20(4):973-81 [PMID: 11844819]
  2. J Clin Oncol. 2016 Nov 1;34(31):3749-3757 [PMID: 27573661]
  3. CA Cancer J Clin. 2012 May-Jun;62(3):147-72 [PMID: 22422631]
  4. Acta Obstet Gynecol Scand. 2019 Aug;98(8):1063-1069 [PMID: 30868579]
  5. Oncologist. 2014 Jul;19(7):727-34 [PMID: 24951611]
  6. Int J Gynecol Cancer. 2018 Sep;28(7):1350-1359 [PMID: 30036225]
  7. Infect Agent Cancer. 2018 May 8;13:16 [PMID: 29760767]
  8. Med Sante Trop. 2017 Feb 1;27(1):16-22 [PMID: 28406406]
  9. Ethiop Med J. 2015 Apr;53(2):65-74 [PMID: 26591294]
  10. Clin Interv Aging. 2013;8:783-8 [PMID: 23836968]
  11. Lancet Glob Health. 2020 Feb;8(2):e191-e203 [PMID: 31812369]
  12. BMC Cancer. 2018 Nov 7;18(1):1075 [PMID: 30404606]
  13. Brachytherapy. 2019 Jan - Feb;18(1):29-37 [PMID: 30361045]
  14. PLoS One. 2018 May 8;13(5):e0196764 [PMID: 29738533]
  15. Jpn J Clin Oncol. 2005 Aug;35(8):464-9 [PMID: 16006573]
  16. J Clin Oncol. 2006 Dec 20;24(36):5687-94 [PMID: 17179104]
  17. Expert Rev Anti Infect Ther. 2017 Jun;15(6):613-627 [PMID: 28440679]
  18. Asian Pac J Cancer Prev. ;17(11):4837-4844 [PMID: 28030908]
  19. Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):457-62 [PMID: 19640191]
  20. BMC Clin Pathol. 2015 Sep 23;15:16 [PMID: 26401120]
  21. Lancet. 1997 Aug 23;350(9077):535-40 [PMID: 9284774]
  22. Acta Oncol. 2012 Sep;51(7):915-21 [PMID: 22928692]
  23. PLoS One. 2017 Jul 25;12(7):e0181415 [PMID: 28742851]
  24. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1434-8 [PMID: 22806169]

MeSH Term

Adult
Age Factors
Cancer Survivors
Cohort Studies
Ethiopia
Female
HIV Infections
Hospitals, Special
Humans
Middle Aged
Neoplasm Staging
Retrospective Studies
Risk Factors
Survival Analysis
Uterine Cervical Neoplasms

Word Cloud

Created with Highcharts 10.0.0CCdeathtimepatientscancer1amongsurvivalpredictors[AHR:95%CI:2EthiopiawomenstatusstudyTikurAnbesaspecializedtreatmentHIVHospitalJune2014methodDataversionanalysisorderindependentageolder9]stagediagnosispositiveBACKGROUND:Cervical4thprevalentfemalesgloballyaround7095newcasesdiagnosedeveryyearsecondcommoncausedeathslimitedevidencewellThusinvestigatedfive-yearadmittedTASH2014-2019METHODS:Facility-basedretrospective-cohortconducted3482019systematicrandomsamplingemployedselectparticipantsextractedpatientcardphonecallsdatacollectedusingandroidCS-EntrytoolanalyzedSPSS23KaplanMeier'susedestimatefunctionsCox-proportionalhazardregressioncarriedidentifyRESULTS:overallincidence31per100person-yearsfollowmedianIQRfollow-upentirecohorts1855896-4965monthsincluded50years41-1late7-25-31]34-38]CONCLUSIONANDRECOMMENDATION:ratehighsignificantassociatedshortenadvancedinfectionreceivingThereforeimprovingearlydetectioninitiationnecessaryimprovepatient'sgovernmentneedsstrengthenroutinescreeningprogramsaddresshigh-riskelderlyPredictorscervicalhospital2019:

Similar Articles

Cited By